Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management

Canadian Journal of Diabetes

Volumn 29, Issue 3, 2005, Pages 186-192

  Leiter, Lawrence A ^a   Yale, Jean François ^b   Chiasson, Jean Louis ^c   Harris, Stewart B ^d   Kleinstiver, Peter ^e   Sauriol, Luc ^f  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e Katalyst Health Technology Assessments   (Canada)

^f Aventis Pharma   (Canada)

Author keywords

Fear of hypoglycemia; Glycemic control; Hypoglycemia

Indexed keywords

GLUCOSE; INSULIN;

ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT CARE; QUESTIONNAIRE; SELF MEDICATION;

EID: 33646678474     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2003;27(suppl 2):S1-S1S2.
2. Yale J-F, Begg I, Gerstein H, et al. 2001 Canadian Diabetes Association clinical practice guidelines for the prevention and management of hypoglycemia in diabetes. Can J Diabetes. 2002;26:22-35.
3. Cox DJ, Irvine A, Gonder-Frederick L, et al. Fear of hypoglycemia: Quantification, validation and utilization. Diabetes Care. 1987;10:617-621.
4. Polonsky WH, Davis CL, Jacobson AM, et al. Correlates of hypoglycemic fear in type I and type II diabetes mellitus. Health Psychology. 1992;11:199-202.
5. Gonder-Frederick L, Cox D, Kovatchev B, et al. The psychosocial impact of severe hypoglycemic episodes on spouses of patients with IDDM. Diabetes Care. 1997;20:1543-1546.
6. Cryer PE. Hypoglycemia: The limiting factor in the management of IDDM. Diabetes. 1994;43:1378-1389.
7. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
8. Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (A1C) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995;44:968-983.
9. Diabetes Control and Complications Trial Research Group. Hypoglycemia in the diabetes control and complications trial. Diabetes. 1997;46:271-286.
10. Reichard P, Pihl M, Rosenqvist U, et al. Complications in IDDM are caused by elevated blood glucose level: the Stockholm Diabetes Intervention Study (SDIS) at 10-year follow-up. Diabetologia. 1996;39:1483-1488.
11. Egger M, Davey Smith G, Stettler C, et al. Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis. Diabet Med. 1997;14:919-928.
12. Polonsky W, Davis A, Jacobson B, et al. Hyperglycemia, hypoglycemia, and blood glucose control in diabetes: Symptom perceptions and treatment strategies. Diabet Med. 1992;9:120-125.
13. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
14. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomised prospective 6-year study. Diabetes Res Clin Pract. 1995;28:103-117.